Gainza-Miranda D, Sanz-Peces E M, Varela Cerdeira M, Prados Sanchez C, Alonso-Babarro A
Equipo de Soporte Paliativo Domiciliario Dirección Asistencial Norte de Madrid, Madrid, Spain.
Equipo de Soporte Paliativo Domiciliario Dirección Asistencial Norte de Madrid, Madrid, Spain.
Heart Lung. 2023 Nov-Dec;62:186-192. doi: 10.1016/j.hrtlng.2023.07.006. Epub 2023 Aug 7.
Access to palliative care for patients with end-stage chronic obstructive pulmonary disease (COPD) is still very poor.
Evaluate our palliative care program for patients with advanced COPD by assessing whether the referral criteria for advanced COPD patients were adequate in identifying patients in end-of-life care and determine the results of the palliative care team's intervention METHODS: This was a prospective observational study of patients admitted to a multidisciplinary unit for advanced COPD. Data on sociodemographic variables, survival, symptomatology, quality of life, ACP, and health resource utilization were analyzed.
Eighty-three patients were included in this study. By the end of the follow-up period, 69 (83%) patients had died, mainly due to respiratory failure (96%). The median duration of survival from the start of follow-up was 4.27 months (95% confidence interval, 1.97-16.07). Most patients (94%) had a dyspnea level of 4. Sixty (72%) patients required opioids for dyspnea control. There were no significant differences in the quality of life of the patients during follow-up. Thirty (43%) patients died at home, 26 (38%) in a palliative care unit, and 13 (19%) in an acute care hospital. ACP was performed for 50 (72%) patients. Forty (57%) patients required palliative sedation during follow-up. Dyspnea was the reason for sedation in 34 (85%) patients. Hospital admissions and emergency room visits decreased significantly (p = 0.01) during follow-up.
Our integrated model allows for adequate selection of patients, facilitates symptom control and ACP, reduces resource utilization, and favors death at home.
晚期慢性阻塞性肺疾病(COPD)患者获得姑息治疗的机会仍然非常少。
通过评估晚期COPD患者的转诊标准在识别临终关怀患者方面是否充分,并确定姑息治疗团队干预的结果,来评估我们针对晚期COPD患者的姑息治疗项目。
这是一项对入住多学科晚期COPD病房的患者进行的前瞻性观察研究。分析了社会人口统计学变量、生存情况、症状、生活质量、预立医疗照护计划(ACP)和卫生资源利用的数据。
本研究纳入了83例患者。在随访期结束时,69例(83%)患者死亡,主要原因是呼吸衰竭(96%)。从随访开始的中位生存时间为4.27个月(95%置信区间,1.97 - 16.07)。大多数患者(94%)的呼吸困难程度为4级。60例(72%)患者需要使用阿片类药物来控制呼吸困难。随访期间患者的生活质量没有显著差异。30例(43%)患者在家中死亡,26例(38%)在姑息治疗病房死亡,13例(19%)在急症医院死亡。50例(72%)患者进行了预立医疗照护计划。40例(57%)患者在随访期间需要姑息性镇静。34例(85%)患者因呼吸困难而接受镇静。随访期间住院和急诊就诊次数显著减少(p = 0.01)。
我们的综合模式能够充分筛选患者,促进症状控制和预立医疗照护计划,减少资源利用,并有利于在家中死亡。